Nothing Special   »   [go: up one dir, main page]

Petersen et al., 1982 - Google Patents

Functional characteristics of synovial fluid and blood mononuclear cells in rheumatoid arthritis and traumatic synovitis

Petersen et al., 1982

Document ID
4026168019570526118
Author
Petersen J
Andersen V
Bendixen G
Bendtzen K
Halkjær-Kristensen J
Ingemann-Hansen T
Wiik A
Publication year
Publication venue
Scandinavian Journal of Rheumatology

External Links

Snippet

The activity of blood mononuclear cells (BMC) and synovial fluid mononuclear cells (SMC) from patients with rheumatoid arthritis (RA) and traumatic synovitis (TS) was assessed by means of [14C] thymidine incorporation and production of leukocyte migration inhibitory …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system

Similar Documents

Publication Publication Date Title
Tagliabue et al. Natural cytotoxicity of mouse monocytes and macrophages
Ogra et al. Immunologic aspects of human colostrum and milk: II. Characteristics of lymphocyte reactivity and distribution of E-rosette forming cells at different times after the onset of lactation
Valle et al. Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to herpes simplex antigen
Maderazo et al. Defective regulation of chemotaxis in cirrhosis
Ohno et al. Detection of gamma interferon in the sera of patients with Behçet's disease
Basham et al. Regulation of expression of class II major histocompatibility antigens on human peripheral blood monocytes and Langerhans cells by interferon
James et al. Immunoregulatory function of T cells activated in the autologous mixed lymphocyte reaction.
Wyler et al. Response of sensitized and unsensitized human lymphocyte subpopulations to Plasmodium falciparum antigens
Lowrey et al. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells
Harvey et al. Immunological competence in non-human primates: differences observed in four species
Sugiyama et al. Effect of Corynebacterium parvum on human T-lymphocyte interferon production and T-lymphocyte proliferation in vitro
Petersen et al. Functional characteristics of synovial fluid and blood mononuclear cells in rheumatoid arthritis and traumatic synovitis
Brown et al. Cloned human T cells synthetize Ia molecules and can function as antigen presenting cells
Stevenson et al. Interaction of pokeweed mitogen with monocytes in the activation of human lymphocytes
Kirchner et al. Effect of A. laidlawii on murine and human lymphocyte cultures.
Warford et al. Characterization of lymphoid cells in the thyroid of patients with Graves' disease.
Han et al. T-lymphocyte dependency of B-lymphocyte blastogenic response to phytomitogens.
Modica et al. HLA‐B8, DR3 phenotype and lymphocyte responses to phytohaemagglutinin
Zychlinsky et al. Cytotoxic mechanisms of murine lymphokine-activated killer cells: functional and biochemical characterization of homogeneous populations of spleen LAK cells
Gilsanz et al. Hemolytic anemia in chronic large granular lymphocytic leukemia of natural killer cells: cytotoxicity of natural killer cells against autologous red cells is associated with hemolysis
Rong et al. Hyperglobulinaemia in chronic liver disease: relationships between in vitro immunoglobulin synthesis, short lived suppressor cell activity and serum immunoglobulin levels.
Labib et al. Immunosuppressive factors in mouse amniotic fluid and neonate serum
EP0179127B1 (en) Leukoregulin, an antitumor lymphokine, and its therapeutic uses
Andersen et al. Inhibition of human lymphocyte blast transformation by streptolysin O
Yamasaki et al. Enhancement of in vitro immunoglobulin synthesis of human lymphocytes by lysosomal enzymes from polymorphonuclear leucocytes.